Your browser doesn't support javascript.
loading
An epidemiologic risk prediction model for ovarian cancer in Europe: the EPIC study.
Li, K; Hüsing, A; Fortner, R T; Tjønneland, A; Hansen, L; Dossus, L; Chang-Claude, J; Bergmann, M; Steffen, A; Bamia, C; Trichopoulos, D; Trichopoulou, A; Palli, D; Mattiello, A; Agnoli, C; Tumino, R; Onland-Moret, N C; Peeters, P H; Bueno-de-Mesquita, H B; Gram, I T; Weiderpass, E; Sánchez-Cantalejo, E; Chirlaque, M-D; Duell, E J; Ardanaz, E; Idahl, A; Lundin, E; Khaw, K-T; Travis, R C; Merritt, M A; Gunter, M J; Riboli, E; Ferrari, P; Terry, K; Cramer, D; Kaaks, R.
Afiliação
  • Li K; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Hüsing A; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Fortner RT; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Tjønneland A; The Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Hansen L; The Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Dossus L; 1] Inserm, Centre for research in Epidemiology and Population Health (CESP), U1018, Nutrition, Hormones and Women's Health team, F-94805 Villejuif, France [2] University Paris Sud, UMRS 1018, F-94805 Villejuif, France.
  • Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Bergmann M; German Institute of Human Nutrition in Potsdam-Rehbruecke, Potsdam, Germany.
  • Steffen A; German Institute of Human Nutrition in Potsdam-Rehbruecke, Potsdam, Germany.
  • Bamia C; Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, Athens, Greece.
  • Trichopoulos D; 1] Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA [2] Bureau of Epidemiologic Research, Academy of Athens, Athens, Greece [3] Hellenic Health Foundation, Athens, Greece.
  • Trichopoulou A; 1] Bureau of Epidemiologic Research, Academy of Athens, Athens, Greece [2] Hellenic Health Foundation, Athens, Greece.
  • Palli D; Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute-ISPO, Florence, Italy.
  • Mattiello A; Dipartimento di Medicina Clinica e Chirurgia, University of Naples Federico II, Naples, Italy.
  • Agnoli C; Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Tumino R; Cancer Registry and Histopathology Unit, 'Civic-M.P. Arezzo' Hospital, Ragusa, Italy.
  • Onland-Moret NC; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Peeters PH; 1] Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands [2] MRC-PHE Centre for Environment and Health, Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
  • Bueno-de-Mesquita HB; Department for Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
  • Gram IT; Department of Community Medicine, Faculty of Health Sciences, The Arctic University of Norway, Tromsø, Norway.
  • Weiderpass E; 1] Department of Community Medicine, Faculty of Health Sciences, The Arctic University of Norway, Tromsø, Norway [2] Department of Research, Cancer Registry of Norway, Oslo, Norway [3] Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Sánchez-Cantalejo E; 1] Escuela Andaluza de Salud Pública, Instituto de Investigación Biosanitaria de Granada (Granada.ibs), Granada, Spain [2] CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
  • Chirlaque MD; 1] CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain [2] Department of Epidemiology, Murcia Regional Health Authority, Murcia, Spain.
  • Duell EJ; Unit of Nutrition, Environment and Cancer Epidemiology Research Program, Bellvitge Biomedical Research Institute (IDIBELL), Catalan Institute of Oncology (ICO), Barcelona, Spain.
  • Ardanaz E; 1] CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain [2] Navarre Public Health Institute, Pamplona, Spain.
  • Idahl A; Department of Clinical Sciences, Obstetrics and Gynecology and Department of Public Health and Clinical Medicine, Nutritional Research Umeå University, Umeå, Sweden.
  • Lundin E; Department of Medical Biosciences, Pathology Umeå University, Umeå, Sweden.
  • Khaw KT; University of Cambridge, School of Clinical Medicine, Cambridge, UK.
  • Travis RC; Cancer Epidemiology Unit, Nuffield Department of Population Health University of Oxford, Oxford, UK.
  • Merritt MA; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, UK.
  • Gunter MJ; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, UK.
  • Riboli E; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, UK.
  • Ferrari P; International Agency for Research on Cancer, Lyon, France.
  • Terry K; 1] Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA [2] Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Cramer D; 1] Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA [2] Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Kaaks R; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Br J Cancer ; 112(7): 1257-65, 2015 Mar 31.
Article em En | MEDLINE | ID: mdl-25742479
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Middle aged País/Região como assunto: Europa Idioma: En Revista: Br J Cancer Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Middle aged País/Região como assunto: Europa Idioma: En Revista: Br J Cancer Ano de publicação: 2015 Tipo de documento: Article